Cost-utility Analysis of Dornase alfa in comparison with Tobramycin for Managing Iranian Patients with Cystic Fibrosis
Background: Cystic fibrosis (CF) is a progressive, life-threatening, and autosomal disease, which is most prevalent in Europe, North America, and Australia. This genetic disorder does not have a curative treatment, and current medications to manage CF including Tobramycin, are associated with high e...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Tehran University of Medical Sciences,
2023-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|